ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
96 hedge funds and large institutions have $49.4M invested in Endocyte, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 31 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
Holders
96
Holding in Top 10
–
Calls
$260K
Puts
$44K
Top Buyers
| 1 | +$2.5M | |
| 2 | +$217K | |
| 3 | +$168K | |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
+$127K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$67.1K |
Top Sellers
| 1 | -$1.81M | |
| 2 | -$957K | |
| 3 | -$488K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$360K |
| 5 |
Morgan Stanley
New York
|
-$311K |